Margaret A. Liu (Vice President, Vaccines Research, Chiron Corporation) reviews a wide range of approaches to vaccine design and development. Consideration is given to the particular strengths and weaknesses of protocols ranging from traditional attenuated organisms to the most innovative transgenic plants and DMA-based vaccines, and how well each is likely to meet our future vaccine needs.
